id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2301180,d79ecd4e-e44b-4d9e-ad14-a8e692be2322,Q2,"MARSHALL & POPP, LLC",401105121,"SANOFI U.S. SERVICES, INC.",2019,second_quarter,CPT,"Patents and protection of intellectual property issues, including S.1416: Affordable Prescriptions for Patients Act of 2019.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Management & Budget (OMB),White House Office",40000,,0,0,2019-07-10T16:56:55.787000-04:00
2301181,d79ecd4e-e44b-4d9e-ad14-a8e692be2322,Q2,"MARSHALL & POPP, LLC",401105121,"SANOFI U.S. SERVICES, INC.",2019,second_quarter,PHA,"Prescription drug value issues.

Biosimilars.

Importation of prescription drugs.

340B issues.

FDA regulatory issues, including the International Pricing Index and Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals.","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Management & Budget (OMB),White House Office",40000,,0,0,2019-07-10T16:56:55.787000-04:00